Advances in the Treatment of Relapsed Small Cell Lung Cancer

Advances in the Treatment of Relapsed Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly malignant tumor. The initial treatment of radiotherapy and chemotherapy are more sensitive, high remission rate, but susceptible to drug resistance and relapse after treatment. Although the treatment of lung cancer has undergone enormous changes in recent ye...

Full description

Bibliographic Details
Main Authors: Bin LIU, Jianwen QIN, Jingmin ZHOU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2017-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Relapsed
Chemotherapy
Targeted therapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2017.03.08

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2017.03.08

Similar Items